AeroSafe Global

company

About

AeroSafe Global develops aerogels used in various transport, biomedical, pharmaceutical, and other temperature-sensitive products.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$3.20M
Industries
Biopharma,Manufacturing,Packaging Services,Pharmaceutical
Founded date
Jan 1, 1995
Number Of Employee
51 - 100
Operating Status
Active

AeroSafe Global develops and produces aerogels and related materials for temperature-sensitive shipping needs in the United States. Its products are used in various thermal insulation applications to transport biomedical, pharmaceutical, and other temperature-sensitive products. The company provides a reliable, simple, and sustainable temperature sensitive supply chain solutions to the world’s leading biopharma companies.

AeroSafe Global delivers cold-chain services for the biopharma industry that results in zero temperature excursions for every client, every product, every time. With proprietary packaging, logistics, and operational services, the company builds customized solutions that ensure the safe delivery of temperature-sensitive biopharmaceuticals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.20M
AeroSafe Global has raised a total of $3.20M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 28, 2007 Series B $3.20M 2 Vimac Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
2
AeroSafe Global is funded by 2 investors. Vimac Ventures and Mount Royal Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Vimac Ventures Yes Series B
Mount Royal Ventures Series B